We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Antigen Profiling of Colorectal Cancer Uses Fluorescence Multiplexing

By LabMedica International staff writers
Posted on 06 Oct 2010
Print article
Surface antigen profiling of colorectal cancer (CRC) tissue has been achieved using antibody microarrays with fluorescence multiplexing.

The profiling method disaggregates CRC and normal intestinal mucosal tissues to produce suspensions of viable single cells, which are then captured on customized antibody microarrays recognizing 122 different surface antigens.

A study was carried out at the University of Sydney, (Sydney, NSW, Australia) to investigate the surface antigens of surgical samples from 40 CRC patients. Cell binding patterns are recorded by optical scanning of microarrays provide a surface profile of antigens on the cells. The DotScan Microarrays were custom-made at Medsaic Pty Ltd., (Eveleigh, NSW, Australia). Subpopulations of cells bound on the microarray were profiled by fluorescence multiplexing using monoclonal antibodies tagged with Quantum Dots or other fluorescent dyes.

Statistical analysis revealed significant differences between profiles for CRC samples and mucosal controls. Hierarchical clustering of CRC data identified several disease clusters that showed some correlation with clinicopathological stage as determined by conventional histopathological analysis. Fluorescence multiplexing using Phycoerythrin- or Alexa Fluor 647-conjugated antibodies was more effective than multiplexing with antibodies labeled with Quantum Dots. This relatively simple method yields a large amount of information for each patient sample and, with further application, should provide disease signatures, and enable the identification of patients with good or poor prognosis.

While the small size of CRC samples precluded separation of mixed CRC populations into subsets of interest prior to profiling, fluorescence multiplexing was used to profile T-cells (CD3+) and epithelial cell adhesion molecule (EpCAM)-expressing cells of epithelial origin in CRC and corresponding normal intestinal mucosa. The study was published in April 2010 issue of the Journal of Immunological Methods.

Related Links:
University of Sydney
Medsaic Pty Ltd.



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.